Endogenous ouabain-like factor (OLF) secretion is modulated by nicotinic mechanisms in rat adrenocortical cells

Life Sciences

Volumn 74, Issue 17, 2004, Pages 2111-2128

  Göõz, Monika ^a,d   Tóth, Miklós ^a,b   Vakkuri, Olli ^c   Göõz, Pal ^d   Smolka, Adam J ^d   De Châtel, Rudolf ^a,b   Szalay, Katalin Sz ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF OULU   (Finland)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adrenal gland; Endogenous ouabain like factor; Hypertension; Nicotine

Indexed keywords

ACETYLCHOLINE; DIGITALIS LIKE FACTOR; HEXAMETHONIUM; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR; PHYSOSTIGMINE;

ADRENAL CORTEX; ADRENAL CORTEX CELL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; DRUG EFFECT; DRUG POTENTIATION; MALE; NONHUMAN; PROTEIN SECRETION; RADIOIMMUNOASSAY; RAT; REGULATORY MECHANISM; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SUPERNATANT; ZONA FASCICULATA; ZONA GLOMERULOSA;

STROPHANTHUS GRATUS;

EID: 1142285259     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.07.058     Document Type: Article

References (50)

1. Abood L.G., Lowy K., Tometsko A., Booth H. Electrophysiological, behavioral, and chemical evidence for a noncholinergic, stereospecific site for nicotine in rat brain. Journal of Neuroscience Research. 3(5-6):1978;327-333.
2. Arias H.R. Topology of ligand binding sites on the nicotinic acetylcholine receptor. Brain Research Reviews. 25(2):1997;133-191.
3. Barbieri R.L., Friedman A.J., Osathanondh R. Cotinine and nicotine inhibit human fetal adrenal 11 beta-hydroxylase. Journal of Clinical Endocrinology and Metabolism. 69(6):1989;1221-1224.
4. Beck M., Szalay K.Sz., Nagy G.M., Tóth M., de Châtel R. Production of ouabain by rat adrenocortical cells. Endocrine Research. 22:1996;845-849.
5. Benyamina M., Leboulenger F., Lirhmann I., Delarue C., Feuilloley M., Vaudry H. Acetylcholine stimulates steroidogenesis in isolated frog adrenal gland through muscarinic receptors: evidence for a sensitization mechanism. Journal of Endocrinology. 113:1987;339-348.
6. Blank U., Ruckes C., Clauss W., Weber W.M. Effects of nicotine on human nasal epithelium: evidence for nicotinic receptors in non-excitable cells. Pflugers Archive. 434(5):1997;581-586.
7. Boulanger B.R., Lilly M.P., Hamlyn J.M., Laredo J., Shurtleff D., Gann D.S. Ouabain is secreted by the adrenal gland in awake dogs. American Journal of Physiology. 264:1993;E413-E419.
8. Conti-Fine B.M., Navaneetham D., Lei S., Maus A.D. Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? European Journal of Pharmacology. 393(1-3):2000;279-294.
9. Garnier M., Lamacz M., Tonon M.C., Vaudry H. Functional characterization of a nonclassical nicotine receptor associated with inositolphospholipid breakdown and mobilization of intracellular calcium pools. Proceedings of the National Academy of Sciences. 91(24):1994;11743-11747.
10. Grando S.A., Horton R.M., Pereira E.F., Diethelm-Okita B.M., George P.M., Albuquerque E.X., Conti-Fine B.M. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. Journal of Investigative Dermatology. 105(6):1995;774-781.
11. i. Journal of Molecular and Cell Cardiology. 29:1997;1615-1627.
12. +-ATPase inhibitors in hypertension-some old and recent findings. Clinical and Experimental Hypertension. 20(5-6):1998;499-508.
13. Hamlyn J.M., Blaustein M.P., Bova S., DuCharme D.W., Harris D.W., Mandel F., Mathew W.R., Ludens J.H. Identification and characterization of a ouabain-like compound from human plasma. Proceedings of the National Academy of Sciences. 88:1991;6259-6263.
14. Hamlyn J.M., Hamilton B.P., Manunta P. Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. Journal of Hypertension. 14:1996;151-167.
15. Holladay M.W., Dart M.J., Lynch J.K. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. Journal of Medical Chemistry. 40:1997;4169-4194.
16. Jánossy A., Orsó E., Szalay K.Sz., Jurányi Z., Beck M., Vizi E.S., Vinson G.P. Cholinergic regulation of the rat adrenal zona glomerulosa. Journal of Endocrinology. 157:1998;305-315.
17. Kasson B.G., Hsueh A.J. Nicotinic cholinergic agonists inhibit androgen biosynthesis by cultured rat testicular cells. Endocrinology. 117(5):1985;1874-1880.
18. Kitano S., Morimoto S., Nishibe A., Fukuo K., Hirotani A., Nakahashi T., Yasuda O., Ogihara T. Exogenous ouabain is accumulated in the adrenals and mimics the kinetics of endogenous digitalis-like factor in rats. Hypertension Research. 21(1):1998;47-56.
19. Klapproth H., Racke K., Wessler I. Acetylcholine and nicotine stimulate the release of granulocyte-macrophage colony stimulating factor from cultured human bronchial epithelial cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 357(4):1998;472-475.
20. Kojima I., Kojima K., Shibata H., Ogata E. Mechanism of cholinergic stimulation of aldosterone secretion in bovine adrenal glomerulosa cells. Endocrinology. 119(1):1986;284-291.
21. Laragh J.H., Sealey J.F. The renin-angiotensin-aldosterone system in hypertensive disorders: a key to two forms of arteriolar vasoconstriction and a possible clue to risk of vascular injury (heart attack and stroke) and prognosis. Laragh J.H., Brenner B.M. Hypertension: Pathophysiology, Diagnosis, and Management. 1990;1329-1348 Raven Press, New York.
22. Laredo J., Hamilton B.P., Hamlyn J.M. Secretion of endogenous ouabain from bovine adrenocortical cells: role of the zona glomerulosa and zona fasciculata. Biochemical and Biophysical Research Communications. 212:1995;487-493.
23. Laredo J., Shah J.R., Lu Z.R., Hamilton B.P., Hamlyn J.M. Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension. 29(1 Pt 2):1997;401-407.
24. Li S., Eim C., Kirch U., Lang R.E., Schoner W. Bovine adrenals and hypothalamus are a major source of proscillaridin A- and ouabain- immunoreactivities. Life Sciences. 62(11):1998;1023-1033.
25. Lichtstein D., Steinitz M., Gati I., Samuelov S., Deutsch J., Orly J. Biosynthesis of digitalis-like compounds in rat adrenal cells: hydroxycholesterol as possible precursor. Life Sciences. 62(23):1998;2109-2126.
26. Macklin K.D., Maus A.D., Pereira E.F., Albuquerque E.X., Conti-Fine B.M. Human vascular endothelial cells express functional nicotinic acetylcholine receptors. Journal of Pharmacological and Experimental Therapeutics. 287(1):1998;435-439.
27. Manunta P., Hamilton J., Rogowski A.C., Hamilton B.P., Hamlyn J.M. Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin. Hypertension Research. 23:2000;S77-S85.
28. Martinka E., Galajada P., Ochodnicky M., Lichardus B., Straka S., Mokan M. Endogenous digoxin-like immunoactivity and diabetes mellitus: facts and hypotheses. Medical Hypotheses. 49(3):1997;271-275.
29. Omwik P. How smoking affects blood pressure. Blood Pressure. 5:1996;71-77.
30. Ottesen M.M., Worck R., Ibsen H. Captopril does not blunt the sympathoadrenal response to cigarette smoking in normotensive humans. Blood Pressure. 6:1997;29-34.
31. Paci A., Ciarimboli G., Biver P. Human placenta radioreceptor assay with digoxin and ouabain to detect endogenous digitalis-like factor(s) in human plasma and urine. Clinical Chemistry. 42:1996;270-278.
32. Parker T.L., Kesse W.K., Mohamed A.A., Afework M. The innervation of the mammalian adrenal gland. Journal of Anatomy. 183:1993;265-276.
33. Patterson T.R., Stringham J.D., Meikle A.W. Nicotine and cotinine inhibit steroidogenesis in mouse Leydig cells. Life Sciences. 46(4):1990;265-272.
34. Perrin A., Brasmes B., Chambaz E.M., Defaye G. Bovine adrenocortical cells in culture synthesize an ouabain-like compound. Molecular and Cellular Endocrinology. 126(1):1997;7-15.
35. Pierdomenico S.D., Bucci A., Manunta P., Rivera R., Ferrandi M., Hamlyn J.M., Lapenna D., Cuccurullo F., Mezzetti A. Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension. American Journal of Hypertension. 14(1):2001;44-50.
36. Qazzaz H.M., El-Masri M.A., Valdes R. Jr. Secretion of a lactone-hydrogenated ouabain-like effector of sodium, potassium-adenosine triphosphatase activity by adrenal cells. Endocrinology. 141(9):2000;3200-3209.
37. Rubin R.P., Warner W. Nicotine-induced stimulation of steroidogenesis in adrenocortical cells of the cat. British Journal of Pharmacology. 53(3):1975;357-362.
38. Schneider R., Wray V., Nimtz M., Lehmann W.D., Kirch U., Antolovic R., Schoner W. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. Journal of Biological Chemistry. 273(2):1998;784-792.
39. Shao Z., Mellor I.R., Brierley M.J., Harris J., Usherwood P.N. Potentiation and inhibition of nicotinic acetylcholine receptors by spermine in the TE671 human muscle cell line. Journal of Pharmacology and Experimental Therapeutics. 286(3):1998;1269-1276.
40. Skowronski R.J., Feldman D. Inhibition of aldosterone synthesis in rat adrenal cells by nicotine and related constituents of tobacco smoke. Endocrinology. 134(5):1994;2171-2177.
41. Szalay K.Sz., Beck M., Tóth M., de Châtel R. Interactions between ouabain, atrial natriuretic peptide, angiotensin-II and potassium: effects on rat zona glomerulosa aldosterone production. Life Sciences. 62:1998;1845-1852.
42. Tymiak A.A., Norman J.A., Bolgar M., DiDonato G.C., Lee H., Parker W.L., Lo L.C., Berova N., Nakanishi K., Haber E., Haupert G.T. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proceedings of the National Academy of Sciences. 90(17):1993;8189-8193.
43. Vakkuri O., Arnason S.S., Pouta A., Vuolteenaho O., Leppaluoto J. Radioimmunoassay of plasma ouabain in healthy and pregnant individuals. Journal of Endocrinology. 165(3):2000;669-677.
44. +-activated adenosinetriphosphatase as a trigger in transmitter release. Neuroscience. 3:1978;367-384.
45. Vizi E.S., Oberfrank F., Bernath S., Lichtstein D. Noradrenaline releasing effect of an ouabain-like compound on pulmonary artery. Neuropharmacology. 26:1987;1541-1544.
46. Yamada Y., Nakazato Y., Ohga A. Ouabain distinguishes between nicotinic and muscarinic receptor-mediated catecholamine secretions in perfused adrenal glands of cat. British Journal of Pharmacology. 96:1989;470-479.
47. Zwart R., Vijverberg H.P. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects. Molecular Pharmacology. 52(5):1997;886-895.
48. Zuo Y., Aistrup G.L., Marszalec W., Gillespie A., Chavez-Noriega L.E., Yeh J.Z., Narahashi T. Dual action of n-alcohols on neuronal nicotinic acetylcholine receptors. Molecular Pharmacology. 60(4):2001;700-711.
49. Zwart R., van Kleef R.G., Gotti C., Smulders C.J., Vijverberg H.P. Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs. Journal of Neurochemistry. 75(6):2000;2492-2500.
50. Zwart R., Vijverberg H.P. Potentiation and inhibition of neuronal α4β4 nicotinic acetylcholine receptors by choline. European Journal of Pharmacology. 393(1-3):2000;209-214.